Member Info for Cloudy390

Yes there will be a capital reduction but it will be on nominal share value ,which is 3p so 3million quid for stem which will only reduce the nominal share value by pence. Derrrrrrrrh.
But the market may absolutely crash it.GLA.

And I’m not taking the mickey, it’s a pivatol time.

And not forgetting Tlzs501 ,which has been stated, can be used in conjunction with foralumab, double whammy, Covid ain’t going away, it has 7 variations now , which may or may not be susceptible to vaccines. Interleukin 6 has been forgotten now but still exists. A treatment ,to me, is necessary.
Imagine all them flights can go, no more worries about catching it, Economies will boom .Take a pill or sniff up your nose sorted. Cmon it’s amazing. Sooooooon.

Yes, big bucks depend on results and a demerger is neither here or there,Accustem,I’m sure will become the market leader but foralumab is now going to prove what Tils is all about, make or break time. To be fair until the different modes of application were patented Foralumab was not good for IV but now as it so strong and can be targeted in small amounts we may see amazing results. GLA.

I reckon foralumab will perform very well and Tils will be sold, leaving Accustem to go through the relevant verification and be ready for marketing in Q1 2021 or sold. Ta dahhhhh.

We all know Accustem is being demergered, we all know main lse listing for tils and acm, what we don’t know foralumab stops Covid in its tracks, eluded to buy experts, but not yet tried. Imagine a world without Covid and others, achieved by kicking our own immune system up the arse. Amazing , value , who knows, I do know that nothing will happen until Covid is solved.

Well they have tested the safety of it and also the right things were found to the happening in the patients bodies and our experts are very excited about the success of the trials, expecting good things to happen. I would suggest there is a very small possibility of things going wrong but I doubt it somehow.

Will be the news that rockets us into mega top tier. Stem will be what it is ,and be validated at a later date, and fda approval at a later date, but Brazil will be the absolute game changer, not long now. GLA.

You don’t know a lot if your asking for answers PMSL.

Know exactly what they have here ! A potentially whole new way.We are now at the ‘pudding eating’ GLA.

Amazing products all no toxic and all showing better medicinal responses than existing . Foralumab a potent anti CD3 monoclonal antibody with no use ,as yet, as not found. With exceptional vision from our board, new delivery methods have been patented,and now in human trials. As I can understand ,Controlling cd3 is controlling the immune system, an immense step forward. For one Tils have,for me been amazing and we are now at the brink of a whole new era. GLA

Why is the whole financial markets against this, can’t they see what’s in front of them, why try to detract from the obvious, Oh it’s to let there mates in. Lol

Lol.

Not like advfn then!

??

Look, just sell ,it’s a scam, we want ya money, so gimme gimme gimme. ??

Lunacy!

It’s a bit sad when people rely on financiers opinions and not expert and scientific evidence.Dont get me wrong I am well above water and could not care about a few quid, but when people go on disregarding expert evidence,ie Royal Marsden , Queen Anne, Eminent Italian institute, its totally unbelievable that people rely on market opinion PMSL.

Agree green, as I didn’t even think about StemprintER all those years ago, and now worth ,who knows, experts say it’s better, as tried by cancer experts. Multi billions, certainly not a side line.Thinking about the ‘Whole caboodle’ it could be astronomical, totally change the future. We are at a point of verification and market realisation of what the outcome will be.

And not a side show for lth as I for one had not a clue what it was all about ,and now a very prominent asset.